A recessive mutation (bir) of E. coli, at 77 min on the standard map, destroys ability of the bacteria to take up biotin or to grow except at high concentrations of biotin. In a biotin prototroph, the bir mutation causes overproduction and excretion of biotin, and derepression of at least one biosynthetic gene (bioD). Growth of the bir mutant is inhibited by avidin or high concentrations of dethiobiotin. Both effects are reversed by biotin.
The enzymes catalyzing biotin biosynthesis in Escherichia coli are determined by a cluster of genes located at 17 min on the genetic map (1) . Another locus (bioH) at 66 min is inferred from the biotin requirement of certain deletion mutants (2) . Fig. 1 shows the main biotin cluster. Three genes (bioA, bioD, and bioF) determine enzymes assayable in vitro (Fig. 2) . Other steps are inferred from feeding studies (3) . Two other genes (bioE and bioG), defined by Rolfe (4), are not included for reasons discussed by Cleary (5) .
Transcription data (6) and complementation studies (5) agree that bioB, bioC, bioF, and bioD constitute an operon transcribed rightward and repressible by biotin.
We report here a recessive mutation mapping at 77 min that causes a defect in biotin transport and derepression of biotin synthesis.
MATERIALS AND METHODS
Bacteria. Table 1 lists strains used, all derivatives of E. coli K-12. Mutagenesis with nitrosoguanidine was performed as described by Adelberg et al. (7) .
Media. Mineral medium (with 20 mM glucose, supplemented with appropriate nutrilites) eosin-methylene blue agar (EMB), and tryptone medium are described elsewhere (8) 
RESULTS
Isolation ofMutants Requiring High Concentrations of Biotin.
Strain R901 was mutagenized with nitrosoguanidine and plated onto minimal agar containing 90 nM biotin. Colonies were replicated onto agar with 2 mM biotin. Of 172 colonies, two (S940 and S941) did not grow well at the lower concentration. The phenotype of S940 proved difficult to score, so only S941 was studied in detail.
Properties of bio-High Requirer. Fig. 3 shows growth of t A5061 = deletion of (galE-AQ), derived from X lysogen (17) . A904 = deletion of (XB-chlA), derived from X lysogen (17), A A266 = deletion of (bioA-chlA) (from P. Cleary). Biotin uptake is shown in Fig. 4 . After our treatment (growth at 100 mM biotin, followed by 2 hr in biotin-free growth medium), R901 takes up biotin at 2 X 10-9 ml cell-1 sec'-(estimated from slope in Fig. 4 and similar Of 91 recombinants, all showed only feeble growth after 2 days with 2 nM biotin, but grew well with 90 nM. Thus, the mutation determining high requirement is not closely linked to the gal-bio region, and affects something besides uptake.
Growth studies of one such recombinant, S942, revealed that: (i) Cultures inoculated at high density (>107 cells/ml) grow well in the absence of added biotin and can be transferred serially at high density. Inoculation at lower densities results in a prolonged lag, but the final extent of growth is comparable to high density cultures. No such effect of density was observed with a bio+ strain (S979) not carrying the mutation for high requirement (data not shown).
(ii) At the concentration used, avidin inhibits growth of S942, but not of S979 (Fig. 5) .
(iii) Low density cultures grow rapidly when supplied with high concentrations of biotin or dethiobiotin (Fig. 5 ). 1-10 nM Dethiobiotin is almost without effect. The optimal concentration is 0.1-1 ;&M. Like S941, strain S942 in the presence of 50 nM biotin is inhibited by 50 MuM dethiobiotin; this inhibition is reversed by 5MuM biotin (data not shown).
Since avidin specifically combines with biotin and related compounds, the avidin inhibition and density dependence suggest that growth in biotin-free media requires accumulation of extracellular biotin.
Assay of the medium in which S942 had grown verified that these cells overproduce and excrete biotin (20-60 mM in the medium, compared to <0.05 nM for the control strains S979 and R881). S942 also accumulated biotin (30-90 nM) in medium containing dethiobiotin (0.09-5 MM), whereas R881 and S979 did not. Assay of dethiobiotin synthetase (Table 2) shows derepression of the bioD gene.
Mapping the Mutation. After bacterial crosses (data not shown) indicated that the mutation for high requirement was near argC and thiA, P1 cotransduction was done with arg, thi, and rif markers. Table 3 shows that the determinant (called bir for "biotin retention") is cotransducible with these genes, the order probably being arg-(rifbir)-thi. Press Strains S941 and S942 are also resistant to phage X. The bir recombinants of Table 3 were sensitive to infection by X.
Properties of bir Transductants. As S941 and S942 differ from the analogous bir+ strains by several mutations, uptake, growth, and derepression were reinvestigated in strains isogenic except for bir and genes cotransducible with it.
The results are similar to those previously observed: (a) bio-bir strains are deficient ih uptake; (b) bio+ bir strains overproduce and excrete biotin; (c) dethiobiotin synthetase is derepressed in bioD+ bir strains (Table 2 , strains S965, S987).
Dominance. To see whether bir was recessive, a heterozygous strain was constructed. Strain S982 was mutagenized with nitrosoguanidine. Two arg mutants were obtained (strains S983 and S984). P1 transduction from an arg+ bir+ donor proved that both arg mutations were linked to bir.
RecA -derivatives of these bir arg mutants were constructed by crossing with strain KL1699, selecting His+ SmR recombinants, and picking an Arg-Bio-Bir-strain sensitive to ultraviolet radiation (S985).
These recA -arg bir bioA bioD+ strains were gown in mixed culture with TR1719, which carries F' factor KLF10. KLF10 contains genes from metB through maiB (76-79 min on the map). Arg+His+ recombinants were picked and maintained on medium lacking arginine.
Of 12 strains tested, all grew on 2 nM biotin. These 12 were grown on tryptone broth with 50 nM biotin, then plated on tryptone agar with biotin. All formed no detectable enzyme, although assay of the bir segregant (S987) shows that the bioD gene is intact. DISCUSSION A mutation (bir) of E. coli has these properties: (i) bio-bir strains are deficient in biotin uptake and require high concentrations of biotin; (ii) bio+ bir strains overproduce and excrete biotin, but grow well only at high concentrations of biotin; (iii) the bir mutation derepresses the bioD gene.
Of the three defects (uptake, retention, and repression), could one cause the other two? Repression cannot be the primary cause: derepression of the biosynthetic genes cannot explain the uptake deficiency of cells from which these genes are absent. Derangement of a membrane transport system could impair both uptake and retention. Certain mutants defective in galactose uptake leak endogenously generated galactose into the medium (14) . Failure to accumulate internal biotin could cause derepression.
If there were no specific transport, a defect in irreversible binding of biotin would also reduce net uptake. The hypothesis of binding sites as an alternative to a specific pump generally creates more problems than it solves. For biotin in E. coli, the sites are not hypothetical. Almost all biotin in growing cells is covalently bound, releasable only by hydrolysis in 6 N H2SO4 (15) . This is true of mutant and wild-type cells used in our uptake studies, both before and after uptake (data not shown). It is at least plausible that the bir mutation might affect binding, rather than transport.
In that case, derepression remains to be explained. The simple inference would be that bound, rather than free, biotin is corepressor. At least, covalent binding and repression would have some step in common.
A defect either in covalent binding or in transport could explain the properties of bir. The two alternatives are not mutually exclusive. Biotin activation (i.e., biotinyl-AMP formation) might reasonably be a step common to both processes.
One question is whether repression depends on the concentration of free intracellular biotin, rather than some derivative thereof. If all consequences of the bir mutation trace back to a reduction in free intracellular biotin, we expect that a high external biotin concentration could reverse them all. We are struck by the enormous difference in the concentration required for growth on the one hand (about 90 mM) and that needed to repress the mutant on the other hand (at least 104-fold greater). The fact that good growth of the bir mutant takes place at concentrations far lower than that required for repression suggests that mutation has affected some element involved in repression at a stage beyond entrance of free biotin into the cell.
